Every 10-Q that Align Technology Inc (ALGN) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ALGN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALGN filings page.
Align Technology reported net revenues of $1,056.2 million for the quarter ended June 30 2026, up 4.3% year over year. Clear Aligner revenues rose to $870.9 million, while Systems and Services declined to $185.3 million. Income from operations was $154.0 million, an operating margin of 14.6%, and net income was $108.3 million, or $1.51 per diluted share. The effective tax rate was 27.2%.
For the first six months of 2026, net revenues reached $2,096.3 million and net income $221.1 million. Operating cash flow was $343.8 million, with cash and cash equivalents of $1,102.6 million at June 30 2026. The company invested in growth and capacity, including capital expenditures and a planned $200 million manufacturing facility in Hyderabad, India expected to start operations in 2027, while repurchasing about 0.4 million shares for $66.7 million. Results were affected by $69.3 million in legal settlements and contingencies for the first half, accelerated depreciation of $15.6 million tied to prior restructuring, and an accrued $37.5 million UK VAT liability following an adverse tribunal decision, even as the company recorded favorable outcomes in certain patent and antitrust litigations.
Align Technology, Inc. reported stronger results for the quarter ended March 31, 2026, with net revenues of $1,040.1 million, up 6.2% year over year, driven mainly by higher clear aligner volumes and slightly higher prices. Net income rose to $112.8 million from $93.2 million, and diluted earnings per share increased to $1.57 from $1.27.
Clear Aligner revenue grew 7.4% to $856 million as case shipments increased 6.7% to 685.7 thousand and revenue per case ticked up. Systems and Services revenue was $184.1 million, up 0.9%. Gross margin improved to 70.8%, helped by operational efficiencies, despite $30.6 million of legal settlement expense and ongoing restructuring costs.
Operating margin was 13.6%. Cash and cash equivalents were $1.06 billion, and operating cash flow was $151.0 million, supporting continued investment in manufacturing and share repurchases. The company highlights macroeconomic headwinds, active patent and antitrust litigation, and a significant but largely completed 2025 restructuring program as key ongoing factors.
Align Technology (ALGN) reported Q3 results with net revenues of $995.7 million and net income of $56.8 million. Diluted EPS was $0.78 versus $1.55 a year ago as costs rose and one‑time items weighed on results.
Gross profit was $639.2 million on cost of net revenues of $356.5 million. Operating expenses were $542.9 million, including $31.8 million of restructuring and other charges. The quarter also included a $23.1 million impairment on assets held for sale and a $14.9 million inventory impairment. Effective tax rate was 40.1%.
By segment, Clear Aligner revenue was $805.8 million and Systems & Services was $189.9 million. Geographically, revenue was $410.6 million in the U.S., $210.8 million in Switzerland, and $374.3 million in other international markets.
Cash and cash equivalents were $1.00 billion, deferred revenues totaled $1.38 billion, and shares outstanding were 71,749,995 as of October 29, 2025. Year‑to‑date, the company repurchased $371.6 million of stock and has $928.4 million remaining under the April 2025 authorization. Align paid $31.75 million into escrow for a preliminarily approved settlement.
Align Technology (ALGN) Q2 2025 10-Q highlights:
- Revenue: $1.01 bn, -1.6% YoY; Clear Aligner -3.3%, Systems & Services +5.6%.
- Margin: Gross margin 70.0% (70.2% LY); operating margin 16.1% vs 14.3% on lower legal costs.
- Earnings: Net income $124.6 m (+29%), diluted EPS $1.72 (+34%). Six-month EPS $2.98 (+11%).
- Cash & Liquidity: Cash & equivalents $901 m (-14% YTD); no debt; operating cash flow $181 m (-4%).
- Capital return: Completed $1 bn Jan-23 buyback; repurchased 1.34 m shares for $225 m in H1; new $1 bn Apr-25 program with $200 m OMR slated for H2.
- Share count: 72.5 m outstanding (-3.5% YoY).
- Legal/one-offs: Recorded $4.2 m additional accrual toward $31.75 m Section-1 antitrust settlement (prelim approval 5/28/25); VAT dispute with UK HMRC refunded ~$100 m but subject to appeal.
- Segment profit: Clear Aligner op-profit $267 m (-11%); Systems & Services $86 m (+21%).
- Balance sheet: Inventories $243.8 m (-4% YTD); goodwill now $491 m after Cubicure acquisition.
- Tax: Effective rate 28.2% vs 32.9%.
Key takeaways: Despite modest top-line contraction, disciplined expense control, share buybacks and favorable other income drove double-digit EPS growth. Cash burn and continuing legal/tax uncertainties temper outlook, but new $1 bn authorization reinforces management’s confidence.